Finally, in another 2011 study, CRC tumors with high Prostaglandin-endoperoxide synthase 2 (PTGS2; also known as Cyclooxygenase-2, COX2) expression were also documented to have decreased ELK1 expression [134]. This evidence concerns the gene ELK1 and colorectal carcinoma.